 | Regenxbio Inc (NASDAQ:RGNX) Expected to Post Earnings of -$0.89 Per Share
www.americanbankingnews.com - October 22 at 7:24 PM |
 | REGENXBIO Announces Presentations at the European Society of Gene & Cell Therapy 27th Annual Congress - PRNewswire
www.prnewswire.com - October 17 at 5:19 PM |
 | REGENXBIO Announces Presentations at the European Society of Gene & Cell Therapy 27th Annual Congress - Yahoo Finance
finance.yahoo.com - October 17 at 7:18 AM |
| REGENXBIO Announces Presentations at the European Society of Gene & Cell Therapy 27th Annual Congress
finance.yahoo.com - October 17 at 7:18 AM |
| Analyzing Regenxbio (NASDAQ:RGNX) & Aevi Genomic Medicine (NASDAQ:GNMX)
www.americanbankingnews.com - October 16 at 1:12 AM |
| Regenxbio Inc (NASDAQ:RGNX) Short Interest Update
www.americanbankingnews.com - October 16 at 12:50 AM |
 | RegenxBio gets positive interim data for eye disease treatment - Washington Business Journal
www.bizjournals.com - October 15 at 5:57 PM |
| RegenxBio gets positive interim data for eye disease treatment
finance.yahoo.com - October 15 at 5:57 PM |
 | Form 8-K REGENXBIO Inc. For: Oct 11 - StreetInsider.com
www.streetinsider.com - October 15 at 12:56 PM |
 | Adverum and Regenxbio go opposite ways on wet AMD data - Seeking Alpha
seekingalpha.com - October 14 at 6:19 PM |
| Regenxbio (RGNX) Reports Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for Treatment of Wet AMD - StreetInsider.com
www.streetinsider.com - October 14 at 8:19 AM |
 | 3 Beaten-Up Biotechs -- Are They Buys? - Motley Fool
www.fool.com - October 13 at 1:04 PM |
| REGENXBIO Announces Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting - PRNewswire
www.prnewswire.com - October 11 at 11:59 PM |
| Big Pharma Has Mad Love For These 2 Biotechs - Motley Fool
www.fool.com - October 11 at 6:58 PM |
| Morgan Stanley Trims Regenxbio (NASDAQ:RGNX) Target Price to $59.00
www.americanbankingnews.com - October 11 at 2:01 PM |
 | Wet AMD Space in Focus: New Drug Approvals & Key Advancements - Nasdaq
www.nasdaq.com - October 10 at 12:15 PM |
| Ultragenyx Gets FDA Approval for Label Expansion of Crysvita - Yahoo Finance
finance.yahoo.com - October 2 at 4:50 PM |
| $6.26 Million in Sales Expected for Regenxbio Inc (NASDAQ:RGNX) This Quarter
www.americanbankingnews.com - October 2 at 1:51 PM |
| REGENXBIO to Present at The Chardan 3rd Annual Genetic Medicines Conference - PRNewswire
www.prnewswire.com - September 30 at 5:40 PM |
| Regenxbio Inc (NASDAQ:RGNX) Expected to Post Earnings of -$0.50 Per Share
www.americanbankingnews.com - September 30 at 6:39 AM |
| Regenxbio Inc (NASDAQ:RGNX) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 30 at 3:29 AM |
| Regenxbio And RGX-501 In Homozygous Familial Hypercholesterolemia - Seeking Alpha
seekingalpha.com - September 20 at 8:45 AM |
| An Intrinsic Calculation For REGENXBIO Inc. (NASDAQ:RGNX) Suggests It's 21% Undervalued
finance.yahoo.com - September 20 at 8:45 AM |
| REGENXBIO (RGNX) Catches Eye: Stock Jumps 5.8% - Yahoo Finance
finance.yahoo.com - September 14 at 12:18 PM |
| This Rockville biotech has added another deal to its growth plan - Washington Business Journal
www.bizjournals.com - September 10 at 11:44 AM |
| REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314 - Yahoo Finance
finance.yahoo.com - September 6 at 5:47 PM |
| REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314 - PRNewswire
www.prnewswire.com - September 5 at 12:01 PM |
 | Clearside Biomedical Shares Rebound On Microinjector Licensing Deal With Regenxbio
www.benzinga.com - September 4 at 11:13 AM |
| 3 Top Biotech Stocks to Buy Right Now - Nasdaq
www.nasdaq.com - August 29 at 11:22 AM |
| REGENXBIO to Present at Upcoming Investor Conferences - PRNewswire
www.prnewswire.com - August 29 at 11:22 AM |
| REGENXBIO to Present at Upcoming Investor Conferences
finance.yahoo.com - August 29 at 11:22 AM |
| REGENXBIO to Present Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting in October - Yahoo Finance
finance.yahoo.com - August 28 at 12:28 PM |
| REGENXBIO to Present Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting in October - PRNewswire
www.prnewswire.com - August 27 at 7:06 PM |
| REGENXBIO to Present Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting in October
finance.yahoo.com - August 27 at 9:36 AM |
| Regenxbio Inc (RGNX) President and CEO Kenneth T. Mills Sold $563,250 of Shares - Yahoo Finance
finance.yahoo.com - August 22 at 12:14 PM |
| Regenxbio Inc (RGNX) President and CEO Kenneth T. Mills Sold $563,250 of Shares
finance.yahoo.com - August 21 at 8:04 PM |
| Edited Transcript of RGNX earnings conference call or presentation 7-Aug-19 8:30pm GMT - Yahoo Finance
finance.yahoo.com - August 12 at 11:56 PM |
| Regenxbio, Inc. (RGNX) CEO Kenneth Mills on Q2 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 9 at 7:29 PM |
| Regenxbio Inc. (RGNX) Q2 2019 Earnings Call Transcript - Yahoo Finance
finance.yahoo.com - August 9 at 7:29 PM |
| Regenxbio Inc. (RGNX) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 9 at 7:29 PM |
| Form 8-K REGENXBIO Inc. For: Aug 07 - StreetInsider.com
www.streetinsider.com - August 9 at 12:28 AM |
| Regenxbio (RGNX) Tops Q2 EPS by 57c, Revenues Miss - StreetInsider.com
www.streetinsider.com - August 9 at 12:28 AM |
| Regenxbio (RGNX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - August 8 at 7:26 PM |
| REGENXBIO Reports Second Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD - PRNewswire
www.prnewswire.com - August 8 at 7:26 PM |
| Edited Transcript of RGNX earnings conference call or presentation 7-Aug-19 8:30pm GMT
finance.yahoo.com - August 8 at 7:26 PM |
| Regenxbio (RGNX) Reports Q2 Loss, Misses Revenue Estimates - Nasdaq
www.nasdaq.com - August 8 at 5:01 AM |
| Is REGENXBIO Inc.'s (NASDAQ:RGNX) CEO Overpaid Relative To Its Peers? - Yahoo Finance
finance.yahoo.com - August 7 at 7:23 PM |
| REGENXBIO Reports Second Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD - Yahoo Finance
finance.yahoo.com - August 7 at 7:23 PM |
| REGENXBIO Reports Second Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
finance.yahoo.com - August 7 at 7:23 PM |
| Regenxbio (RGNX) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 7 at 7:23 PM |
